Biotech Firm Turns To IT To Aid Life-Saving Research

摘要

Caprion Pharmaceuticals Inc. is accelerating its work studying the nature and function of proteins, as it races against competitors such as Celera Genomics Corp. to provide data that drug companies can use to fight disease. The Montreal biotechnology company, which has raised more than $37.5 million since January for its new bioinformatics division, has signed a deal with CGI Group Inc. to help it create the IT infrastructure it needs to support its research.